Search Results

Cyclopamine 100 mg  | Purity Not Available

TargetMol

Cyclopamine, a Smoothened (Smo) antagonist (IC50: 46 nM in TM3Hh12 cells), belongs to the group of steroidal jerveratrum alkaloids.

More Information Supplier Page

Pexmetinib 50 mg  | 99.07%

TargetMol

Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.

More Information Supplier Page

Pexmetinib 2 mg  | 99.07%

TargetMol

Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.

More Information Supplier Page

Selisistat 200 mg  | 99.67%

TargetMol

EX 527 is an effective and specific SIRT1 inhibitor (IC50: 38 nM) and shows >200-fold selectivity against SIRT2/3.

More Information Supplier Page

Selisistat 100 mg  | 99.67%

TargetMol

EX 527 is an effective and specific SIRT1 inhibitor (IC50: 38 nM) and shows >200-fold selectivity against SIRT2/3.

More Information Supplier Page

Selisistat 50 mg  | 99.67%

TargetMol

EX 527 is an effective and specific SIRT1 inhibitor (IC50: 38 nM) and shows >200-fold selectivity against SIRT2/3.

More Information Supplier Page

E-64 100 mg  | Purity Not Available

TargetMol

E-64 (Proteinase inhibitor E 64) is an irreversible and specific cysteine protease inhibitor. The IC50 of E-64 for papain is 9 nM.

More Information Supplier Page

Pioglitazone hydrochloride 200 mg  | 99.66%

TargetMol

Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity.

More Information Supplier Page

BW-A 78U 10 mg  | 99.65%

TargetMol

BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.

More Information Supplier Page